Semiconductor technology for particle accelerators

Corporate Technology (CT), Siemens global research department, has developed a new accelerator technology in cooperation with one of its strategic partners, the Russian research center Skolkovo, which is located near Moscow.

From blank round to a potently active substance?

A long-forgotten candidate for antiviral therapy is undergoing a renaissance: Since the 1970s, the small molecule CMA has been considered a potent agent against viral infections, yet it was never approved for clinical use. ...

page 25 from 27